Quick Answer
Humacyte, Inc. reported Shares Outstanding of 193.00 million shares for fiscal year 2025.
Humacyte, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 193.00M | +48.4% |
| 2024 | 130.03M | +25.4% |
| 2023 | 103.67M | +0.4% |
| 2022 | 103.23M | +0.2% |
| 2021 | 103.00M | +0.0% |
| 2021 | 103.00M | +1669.1% |
| 2020 | 5.82M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 158.84M | +32.5% | +1.6% |
| June 30, 2025 | 156.34M | +31.0% | +0.8% |
| March 31, 2025 | 155.12M | +30.3% | +19.3% |
| December 31, 2024 | 130.03M | +25.4% | +8.5% |
| September 30, 2024 | 119.84M | +15.8% | +0.4% |
| June 30, 2024 | 119.35M | +15.4% | +0.2% |
| March 31, 2024 | 119.08M | +15.2% | +14.9% |
| December 31, 2023 | 103.67M | +0.4% | +0.2% |
- Humacyte, Inc. showed an increase of +48.4% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Humacyte, Inc.’s shares outstanding has grown by 3214.8% (from 5.82 million shares to 193.00 million shares).
- The most recent figure is from Humacyte, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: